ARM Options Traders Turn Cautious as Stock Rallies 20% in a Month

The Street's relationship with ARM is complicated by a wide gap between the current price and where analysts set their targets after July's results. The stock closed Tuesday at $302.56, up 20% over the past month, but the mean analyst price target is around $291. Most of the recent target moves came after the July 29 earnings release, when a cluster of firms including UBS, TD Cowen, RBC Capital and Wells Fargo all cut their targets, some sharply. Morgan Stanley, which carries an Equal-Weight, raised its target to $212 after that print, a level the stock has long since surpassed. The analyst recommendation divergence score ranks in the 97th percentile of the universe, reflecting how stretched the gap between the bull and bear camps has become. Bulls point to ARM's 20% royalty revenue CAGR target through 2031, the Armv9 architecture cycle, and an expanding footprint in cloud AI data centres. Bears flag the SoftBank dependency, which accounts for roughly 15% of sales, and the risk that rising royalty rates could push customers toward alternative architectures. The valuation adds to the tension: the trailing PE has expanded to around 106 times earnings, up more than 15 points over the past month, while EV/EBITDA sits at 85 times.

Wikipedia page traffic provides one piece of context worth noting. The retail attention signal, measured as the z-score of daily English Wikipedia article views and ORTEX page visits against ARM's own 90-day history, ran at a z-score of 2.66 as of early September. That is a high reading by the stock's own standards. The dataset carries no measured lead to the company's financial results, so it is colour rather than signal, but a spike in retail attention during a sharp rally in a high-multiple name is worth observing.

Insider activity adds one data point on the other side. CFO Jason Child sold 10,400 shares on September 21 at $300 for roughly $3.1 million, under a pre-arranged 10b5-1 plan. He made an identical sale in late August at $255. Both were scheduled trades, not discretionary calls on valuation, so they carry limited informational weight. The 90-day net position across all insiders is minus 20,800 shares worth approximately $5.8 million, concentrated in those two CFO plan sales. The CEO's only recent transaction was a nominal award of 64 shares.

Earnings history provides a sobering backdrop. The two most recent prints, September 2026 and July 2026, both produced a negative one-day reaction, down 2.8% and down 1.3% respectively. The five-day picture was more mixed: minus 6.7% after September's release and plus 12.2% after July's. That pattern, initial selling followed by divergent recoveries, reflects how much the post-earnings move depends on guidance rather than the headline number. The next print is due November 4. With peers AMD up nearly 7% on the week and MRVL up 9%, ARM's 3% weekly gain looks modest given the multiple. What to watch is whether the options defensive positioning ahead of November 4 resolves through time decay or whether it sharpens as the date approaches, and whether any analyst moves the consensus target back above the current price.